0,846  0,010  Antiinflammatory
0,830  0,006  CYP2C9 substrate
0,824  0,014  Apoptosis agonist
0,806  0,004  CYP2C19 substrate
0,772  0,004  Carcinogenic, group 3
0,767  0,003  UGT1A4 substrate
0,734  0,005  Skin irritative effect
0,721  0,009  Chemoprotective
0,713  0,019  Antineoplastic (breast cancer)
0,694  0,014  Antileukemic
0,667  0,006  Antineoplastic (pancreatic cancer)
0,671  0,013  Carcinogenic
0,666  0,008  Antineoplastic (melanoma)
0,656  0,002  Vanilloid agonist
0,656  0,005  Psychostimulant
0,668  0,019  Teratogen
0,662  0,013  Respiratory analeptic
0,660  0,011  Antineoplastic (ovarian cancer)
0,669  0,022  Antineoplastic (lung cancer)
0,654  0,007  Immunosuppressant
0,638  0,005  Antineoplastic (endocrine cancer)
0,650  0,019  Embryotoxic
0,627  0,006  UGT1A1 substrate
0,620  0,010  Antiepileptic
0,629  0,020  Antineoplastic (colorectal cancer)
0,609  0,003  TRPA1 agonist
0,604  0,010  NOS2 expression inhibitor
0,608  0,014  Sensitization
0,598  0,005  Sedative
0,612  0,021  Antineoplastic (colon cancer)
0,580  0,002  Alcohol dehydrogenase substrate
0,570  0,016  Antineoplastic (cervical cancer)
0,562  0,012  Nitric oxide antagonist
0,552  0,016  Proliferative diseases treatment
0,539  0,004  Antiviral (Influenza A)
0,541  0,010  Angiogenesis stimulant
0,549  0,020  Bone diseases treatment
0,546  0,018  Analeptic
0,521  0,004  Pneumotoxic
0,529  0,014  Antiprotozoal (Leishmania)
0,524  0,011  UDP-glucuronosyltransferase substrate
0,517  0,012  Antiglaucomic
0,507  0,004  UGT2B7 substrate
0,507  0,004  5 Hydroxytryptamine uptake stimulant
0,503  0,003  UGT2B9 substrate
0,510  0,019  Antipsoriatic
0,504  0,020  Antiosteoporotic
0,488  0,005  Antiviral (Influenza)
0,490  0,016  Antiparasitic
0,489  0,020  Chemopreventive
0,511  0,043  Transcription factor NF kappa B inhibitor
0,479  0,011  Antihelmintic
0,467  0,006  Antiacne
0,484  0,035  Prostate cancer treatment
0,475  0,026  Antifungal
0,473  0,026  FMO1 substrate
0,471  0,025  AR expression inhibitor
0,493  0,048  TNF expression inhibitor
0,451  0,025  Mutagenic
0,432  0,009  Platelet adhesion inhibitor
0,430  0,007  Antialcoholic
0,427  0,010  Hair growth stimulant
0,414  0,012  Antineoplastic (carcinoma)
0,412  0,011  Antihypotensive
0,418  0,019  Myocardial infarction treatment
0,402  0,005  Expectorant
0,430  0,034  Spasmolytic
0,405  0,015  Abortion inducer
0,435  0,056  GST A substrate
0,405  0,035  Antineoplastic (glioma)
0,419  0,059  Antipruritic, allergic
0,378  0,018  Muscle relaxant
0,385  0,025  Antimitotic
0,369  0,010  Acaricide
0,375  0,017  Antiviral (HIV)
0,377  0,027  Vasodilator
0,351  0,003  Aldehyde dehydrogenase substrate
0,376  0,031  Tumour necrosis factor alpha release inhibitor
0,349  0,009  CYP2B6 inhibitor
0,383  0,044  Antineoplastic (brain cancer)
0,377  0,039  Antioxidant
0,409  0,073  Antibacterial
0,357  0,032  Antineoplastic (liver cancer)
0,340  0,018  Antianorexic
0,357  0,040  Antineoplastic (multiple myeloma)
0,417  0,101  Caspase 9 stimulant
0,333  0,025  Eye irritation, high
0,307  0,003  Ca(v)3.1 blocker
0,344  0,040  Cardiovascular analeptic
0,332  0,034  DNA synthesis inhibitor
0,299  0,004  GABA C receptor antagonist
0,353  0,060  ICAM1 expression inhibitor
0,373  0,081  Antiprotozoal
0,299  0,010  Antifungal enhancer
0,309  0,021  Melanin inhibitor
0,330  0,050  UGT2B4 substrate
0,284  0,004  Actinic keratosis treatment
0,357  0,082  GABA C receptor rho-3 antagonist
0,295  0,021  Interferon gamma antagonist
0,322  0,048  Cytotoxic
0,322  0,052  Antineurogenic pain
0,275  0,007  Choleretic
0,294  0,028  VCAM1 expression inhibitor
0,264  0,003  TRPM8 blocker
0,297  0,039  Sigma receptor agonist
0,302  0,051  Antineoplastic (renal cancer)
0,276  0,027  Antiviral (Herpes)
0,252  0,004  CYP2A6 inhibitor
0,253  0,005  Vanilloid 1 agonist
0,271  0,025  Antihelmintic (Nematodes)
0,316  0,074  CYP2D6 substrate
0,250  0,009  Microtubule formation inhibitor
0,245  0,005  Posttraumatic stress disorder treatment
0,275  0,038  RNA-directed DNA polymerase inhibitor
0,287  0,051  Antineoplastic (glioblastoma multiforme)
0,321  0,090  CYP3A4 substrate
0,261  0,031  Antipruritic, non-allergic
0,287  0,058  GST M1-1 substrate
0,310  0,082  Calcium channel activator
0,299  0,071  Antineoplastic (osteosarcoma)
0,237  0,011  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,282  0,058  Interleukin agonist
0,273  0,050  Dependence treatment
0,239  0,017  ATPase inhibitor
0,303  0,084  Apoptosis antagonist
0,291  0,073  5 Hydroxytryptamine release stimulant
0,239  0,026  Succinate dehydrogenase inhibitor
0,269  0,057  Antineoplastic (lymphocytic leukemia)
0,291  0,083  Caspase 3 stimulant
0,228  0,021  UGT2B10 substrate
0,210  0,005  5-Alpha-reductase inhibitor
0,234  0,030  Prostate disorders treatment
0,217  0,018  Antineoplastic antibiotic
0,314  0,115  CYP2C19 inhibitor
0,250  0,055  Antiparkinsonian, rigidity relieving
0,196  0,014  Mucolytic
0,217  0,036  Protein kinase stimulant
0,199  0,019  Movement disorders treatment
0,200  0,022  Ferrochelatase inhibitor
0,189  0,013  Antiviral (Influenza B)
0,199  0,022  Farnesoid X receptor antagonist
0,310  0,134  Antiparkinsonian
0,309  0,135  Analgesic
0,265  0,090  Immunostimulant
0,261  0,092  FMO3 substrate
0,264  0,097  CTGF expression inhibitor
0,221  0,054  Hepatoprotectant
0,176  0,010  Antiprotozoal (Toxoplasma)
0,199  0,034  Arachidonic acid antagonist
0,220  0,057  Non-steroidal antiinflammatory agent
0,165  0,005  ATPase (Vacuolar H+) inhibitor
0,234  0,076  Free radical scavenger
0,186  0,028  Autism spectrum disorders treatment
0,195  0,037  Carcinogenic, group 1
0,195  0,042  CNS active muscle relaxant
0,193  0,039  Insulin secretagoues
0,163  0,012  Anabolic
0,259  0,109  Interleukin 2 agonist
0,163  0,013  Inducible nitric-oxide synthase inhibitor
0,308  0,160  Alzheimer's disease treatment
0,194  0,045  Acetylcholine M1 receptor antagonist
0,263  0,116  Cholesterol antagonist
0,224  0,080  Cytostatic
0,176  0,033  Antifungal (Cryptococcus)
0,156  0,015  Transcription factor NF kappa B stimulant
0,142  0,004  Vanilloid 4 agonist
0,184  0,048  Contraceptive
0,164  0,029  GABA C receptor agonist
0,170  0,035  Adenylate cyclase stimulant
0,233  0,098  Transcription factor STAT3 inhibitor
0,232  0,100  Transcription factor STAT inhibitor
0,155  0,023  DNA directed RNA polymerase inhibitor
0,141  0,009  Glycine receptor antagonist
0,169  0,038  Alkylator
0,139  0,009  Cannabinoid CB2 receptor antagonist
0,161  0,031  Menstruation disorders treatment
0,225  0,096  Tyrosine 3 hydroxylase inhibitor
0,180  0,051  UGT2B15 substrate
0,146  0,018  Antiviral (SARS coronavirus)
0,146  0,018  Antiviral (Coronavirus)
0,207  0,079  Antihypertriglyceridemic
0,172  0,045  Antiseptic
0,188  0,062  Antineoplastic (gastric cancer)
0,141  0,016  Antiviral (Rhinovirus)
0,156  0,031  Ca2+-transporting ATPase inhibitor
0,142  0,019  UGT2B11 substrate
0,235  0,112  CYP1A2 substrate
0,131  0,011  Na+ K+ transporting ATPase inhibitor
0,141  0,022  GST T1-1 substrate
0,171  0,053  Antineoplastic (squamous cell carcinoma)
0,129  0,013  GABA aminotransferase inhibitor
0,162  0,049  M17 leucyl aminopeptidase inhibitor
0,136  0,025  Acetylcholine nicotinic antagonist
0,173  0,065  Antimutagenic
0,111  0,004  Retinoid X receptor agonist
0,216  0,109  Flavin-containing monooxygenase substrate
0,175  0,069  3C-like protease (Human coronavirus) inhibitor
0,217  0,112  5 Hydroxytryptamine 1E antagonist
0,126  0,022  Ornithine decarboxylase inhibitor
0,145  0,041  Carcinogenic, group 2B
0,131  0,028  Androgen antagonist
0,109  0,006  Kainate receptor antagonist
0,205  0,102  Antihypercholesterolemic
0,105  0,003  Kainate receptor agonist
0,261  0,158  Antineoplastic (myeloid leukemia)
0,141  0,041  Contraceptive female
0,119  0,019  CDC25A inhibitor
0,101  0,002  Tubulin agonist
0,126  0,027  Antihypermotility
0,152  0,054  Alpha-N-acetylglucosaminidase inhibitor
0,098  0,001  Vanilloid 2 agonist
0,101  0,005  Anesthetic inhalation
0,111  0,017  Narcotic antagonist
0,111  0,019  HIV-1 integrase (Strand Transfer) inhibitor
0,095  0,002  Adenosine uptake inhibitor
0,097  0,007  Postcoital contraceptive
0,301  0,211  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,152  0,063  SULT1A3 substrate
0,108  0,019  T cell inhibitor
0,197  0,110  Antipyretic
0,104  0,019  Glycine receptor agonist
0,118  0,033  Antifungal (Aspergillus)
0,236  0,153  Antiprotozoal (Plasmodium)
0,105  0,027  Nicotinic alpha4beta2 receptor antagonist
0,121  0,044  GST P1-1 substrate
0,122  0,045  Electron transport complex I inhibitor
0,192  0,117  Vascular (periferal) disease treatment
0,106  0,032  Antibiotic
0,212  0,138  Hypoxia-inducible factor 1 alpha inhibitor
0,116  0,043  GABA C receptor rho-1 antagonist
0,109  0,036  Antidote, mercury
0,077  0,005  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,143  0,072  Cell wall synthesis inhibitor
0,189  0,117  Antidiabetic symptomatic
0,136  0,065  Skin whitener
0,128  0,057  Protein-tyrosine phosphatase 1B inhibitor
0,152  0,082  Uterine stimulant
0,074  0,005  Microtubule stabilization
0,124  0,055  Shock treatment
0,127  0,059  Cholesterol synthesis inhibitor
0,097  0,030  Cannabinoid receptor antagonist
0,122  0,055  Antiviral (CMV)
0,071  0,004  Glutamate (mGluR1) agonist
0,126  0,061  Beta amyloid protein antagonist
0,114  0,049  Antiemetic
0,205  0,141  Gastrin inhibitor
0,087  0,022  Cannabinoid CB1 receptor antagonist
0,110  0,046  Nitric-oxide synthase inhibitor
0,212  0,149  Prostaglandin dehydrogenase inhibitor
0,106  0,042  Carcinogenic, group 2A
0,162  0,100  Antirickettsial
0,227  0,165  Ulceration
0,084  0,023  TRPA1 antagonist
0,145  0,086  Neuropathy treatment
0,118  0,059  Photosensitizer
0,194  0,135  Amyotrophic lateral sclerosis treatment
0,081  0,023  Glutamate (mGluR6) antagonist
0,126  0,068  Cholinergic antagonist
0,160  0,103  Anesthetic general
0,124  0,067  Acetylcholine antagonist
0,099  0,043  Interleukin 5 antagonist
0,143  0,088  CF transmembrane conductance regulator agonist
0,129  0,074  Anesthetic
0,072  0,017  Nicotinic alpha3beta2 receptor antagonist
0,059  0,005  Vanilloid 3 antagonist
0,069  0,014  Aldosterone antagonist
0,075  0,021  Calcium channel P-type blocker
0,070  0,017  Dihydroorotate oxidase inhibitor
0,077  0,023  Hypercalcemia treatment
0,105  0,051  Tourette's syndrome treatment
0,093  0,041  3C-Like protease (SARS coronavirus) inhibitor
0,099  0,048  Triose-phosphate isomerase inhibitor
0,136  0,085  Genotoxic
0,166  0,115  Antiulcerative
0,200  0,150  NOS3 expression inhibitor
0,067  0,018  Pregnane X receptor antagonist
0,080  0,032  Bcl2 antagonist
0,058  0,011  GABA uptake inhibitor
0,078  0,030  Cannabinoid CB1 receptor agonist
0,051  0,003  Alpha 2b adrenoreceptor agonist
0,180  0,133  Hypoglycemic
0,054  0,007  5-Alpha-reductase 1 inhibitor
0,094  0,047  Antispirochetal
0,059  0,012  Kainate receptor 2 antagonist
0,073  0,026  Transcription factor RelA inhibitor
0,057  0,010  Retinoic acid alpha receptor agonist
0,101  0,054  Prolactin inhibitor
0,070  0,024  Protein 50S ribosomal subunit inhibitor
0,210  0,165  Antithrombotic
0,054  0,009  Retinoid X receptor antagonist
0,137  0,093  GABA C receptor rho-2 antagonist
0,062  0,017  Estrogen receptor beta agonist
0,065  0,022  Aconitate hydratase inhibitor
0,073  0,030  Biliverdin reductase inhibitor
0,114  0,071  Proteasome inhibitor
0,045  0,003  Progesterone receptor B antagonist
0,054  0,013  Retinoid X alpha receptor agonist
0,180  0,139  Antiprotozoal (Trypanosoma)
0,084  0,044  Porphobilinogen synthase inhibitor
0,045  0,006  Retinoic acid receptor agonist
0,047  0,008  Retinoid X alpha receptor antagonist
0,088  0,049  Antiprotozoal activity enhancer
0,070  0,032  Antimycoplasmal
0,075  0,038  Cannabinoid receptor agonist
0,053  0,017  Parathyroid hormone antagonist
0,096  0,061  Lanosterol 14 alpha demethylase inhibitor
0,072  0,038  Exportin-1 inhibitor
0,170  0,136  5 Hydroxytryptamine 3E antagonist
0,070  0,038  Hyperparathyroidism treatment
0,119  0,087  Cocaine dependence treatment
0,139  0,107  Antiviral (Hepatitis C)
0,073  0,042  Neuronal nicotinic receptor antagonist
0,062  0,032  Ryanodine receptor antagonist
0,107  0,077  Anesthetic local
0,036  0,007  Retinoid X gamma receptor antagonist
0,117  0,088  Bone formation stimulant
0,139  0,111  Diabetic retinopathy treatment
0,100  0,072  UGT2B1 substrate
0,059  0,031  Estrogen agonist
0,079  0,051  Antidote, organophosphates
0,117  0,090  Papain-like protease (SARS coronavirus) inhibitor
0,083  0,056  CC chemokine 5 receptor agonist
0,132  0,105  Prostatic (benign) hyperplasia treatment
0,144  0,118  Phospholipase C inhibitor
0,058  0,031  Nicotinic receptor alpha7 subunit antagonist
0,031  0,006  Retinoic acid gamma receptor agonist
0,090  0,065  ABCA1 expression enhancer
0,034  0,009  Retinoid X gamma receptor agonist
0,063  0,038  Alpha 2 adrenoreceptor agonist
0,029  0,004  Retinoid X beta receptor antagonist
0,097  0,073  Adenylate kinase inhibitor
0,227  0,203  Transcription factor inhibitor
0,062  0,039  Androgen agonist
0,081  0,059  Acetylcholine M3 receptor agonist
0,039  0,017  Melatonin 2 agonist
0,092  0,070  Electrolyte absorption antagonist
0,053  0,032  Prolyl endopeptidase inhibitor
0,068  0,049  SULT2A1 substrate
0,027  0,009  Vitamin D receptor antagonist
0,030  0,012  Nicotinic acid receptor 2 antagonist
0,025  0,007  Retinoic acid beta receptor agonist
0,074  0,057  Keratolytic
0,045  0,028  Glutamate (mGluR group III) antagonist
0,027  0,010  Retinoid X beta receptor agonist
0,103  0,087  Acetylcholine muscarinic antagonist
0,047  0,031  Adenylate cyclase 1 inhibitor
0,049  0,033  Dopamine beta hydroxylase inhibitor
0,044  0,029  Glutamate (mGluR4) antagonist
0,151  0,137  Neurotrophic factor enhancer
0,093  0,080  AMP-activated protein kinase stimulant
0,109  0,095  Antihyperlipoproteinemic
0,047  0,035  Cholesterol esterase inhibitor
0,092  0,080  Estrogen receptor beta antagonist
0,048  0,036  Cytokine production stimulant
0,025  0,014  CYP24 inhibitor
0,039  0,028  Membrane dipeptidase inhibitor
0,022  0,012  5-Alpha-reductase 2 inhibitor
0,055  0,045  Aromatase inhibitor
0,015  0,005  Calcineurin inhibitor
0,083  0,074  Paget's disease treatment
0,092  0,083  Beta glucuronidase inhibitor
0,063  0,054  Phosphofructokinase-1 inhibitor
0,034  0,026  Progesterone antagonist
0,066  0,058  Dysmenorrhea treatment
0,058  0,050  HIV-1 integrase (3'-Processing) inhibitor
0,095  0,087  SULT1A1 substrate
0,065  0,057  Anticholelithogenic
0,017  0,010  O6-alkylguanine-DNA alkyltransferase inhibitor
0,087  0,081  Bile acid receptor antagonist
0,032  0,025  Estrogen receptor alpha agonist
0,177  0,170  Antineoplastic (sarcoma)
0,011  0,005  Progesterone receptor A antagonist
0,021  0,015  Kainate receptor 1 antagonist
0,154  0,149  Antineoplastic (non-small cell lung cancer)
0,119  0,115  Protein-tyrosine phosphatase inhibitor
0,051  0,047  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,018  0,015  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,016  0,013  Vitamin D receptor agonist
0,009  0,007  Corticotropin releasing factor antagonist
0,091  0,089  Antiinfertility, female
0,142  0,140  Anticonvulsant
0,030  0,028  Calcium release-activated channel blocker
0,016  0,016  Retinoic acid receptor antagonist
0,014  0,013  NMDA receptor phencyclidine site antagonist

